GILD  valuation analysis

Basics
Name: Gilead Sciences, Inc
Description: Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $81.89B (93rd)
Sales(TTM): $24.69B (102nd)
Earnings(TTM): $89.00M (778th)

Value
FFER: 1.17 (why)
Actual price: $65.30
FFEThis is Gilead Sciences, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $55.68
Quantile: GILD is expensive given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Gilead Sciences, Inc
"Drug Manufacturers-General" industry
Sales / MarketCap
Gilead Sciences, Inc
"Drug Manufacturers-General" industry
Book / MarketCap
Gilead Sciences, Inc
"Drug Manufacturers-General" industry
Equity / Assets
Gilead Sciences, Inc
"Drug Manufacturers-General" industry